Benefit of daily FeNO measurement in asthmatics over 12 weeks: adherence, handling and overall satisfaction in the FeNO@home observational study. - Vienna 2024

Asthma biomarkers in high and low type-2 phenotypes

Chair(s): Giuseppe Guida, Laura Bergantini

Session type: Poster session

Benefit of daily FeNO measurement in asthmatics over 12 weeks: adherence, handling and overall satisfaction in the FeNO@home observational study.

Kai Michael Beeh

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Cost effectiveness of using sputum differential cell count in chronic respiratory diseases

Ga Tavernier

Poster

Abstract

Exhaled nitrix oxide in asthma: relationship with blood eosinophils and total IgE

Eugerta Dilka

Poster

Abstract

Diagnostic values of peripheral blood eosinophil count, fractional exhaled nitric oxide, and total serum IgE in eosinophilic asthma

Miaomiao Zhou

Abstract

FeNO variations and clinical response to biological drugs in severe asthma: A retrospective analysis

Claudio Candia

Poster

Abstract

Benefit of daily FeNO measurement in asthmatics over 12 weeks: adherence, handling and overall satisfaction in the FeNO@home observational study.

Kai Michael Beeh

Poster

Abstract

Discrepancies in exhaled nitric oxide results at different flow rates and their correlation with peripheral and airway eosinophils

Min Zhang

Poster

Abstract

Inflammatory Action of Exhaled Breath Condensate from Children with Severe Asthma on Cultures of Human Respiratory Epithelium: Mechanisms and Relationship with Clinical and Functional Characteristics

Carlos Tomas Velasco Suarez

Poster

Abstract

Eosinophilia in blood and sputum in patients with severe asthma: a preliminary study

Victor Guerra Ruiz

Poster

Abstract

Extrapulmonary treatable traits in pregnant women with asthma

Esha Joshi

Poster

Abstract

Hot but not twitchy Eosinophilic airway inflammation dissociates from variable airflow obstruction with increasing asthma severity

Laurits Fr?ssing

Poster

Abstract

FENO stability in repeated measurements during three consecutive days and its association with environmental air pollution in asthma patients.

Juan Jos Ruiz Cubillan

Poster

Abstract

Peripheral airway resistance and reactance are associated to symptom severity in asthmatic subjects

Georgia Papapostolou

Abstract

Lung function provides better insight into the sex-related differences among severe asthmatics than biomarkers.

Elisa Bentivegna

Poster

Abstract

Higher triglyceride-glucose index and lower type 2 inflammation are associated with increased risk of asthma exacerbations: a prospective cohort study

Ke Deng

Poster

Abstract

Type-2 biomarker elevation across asthma treatment steps in the ORACLE patient-level meta-analysis of all-comer trials

Simon Couillard

Poster

Abstract

Asthma Phenotypes and Endotypes in Uncontrolled Asthma and Eligibility Assessment for Biologics in Severe Asthma Subset: an Indian Perspective

Randeep Guleria

Poster

Abstract

Elevated fractional exhaled nitric oxide is prevalent in those with mild-to-moderate asthma with self-reported asthma control

Annemie Deiteren

Poster

Abstract

Effect of Overweight/Obesity on Relationship Between Fractional Exhaled Nitric Oxide and Airway Hyperresponsiveness in Chinese Elderly Patients with Asthma

Fengjia Chen

Poster

Abstract

Additive prognostic value of blood eosinophils and exhaled nitric oxide (FeNO) to predict asthma attacks in the ORACLE patient-level meta-analysis

Simon Couillard

Poster

Abstract

Diagnostic testing in a population of symptomatic adults receiving ICS for presumed asthma.

Patrick Kerr

Abstract

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}